Alkermes Plc (ALKS)
48.85
+0.52
(+1.08%)
USD |
NASDAQ |
Aug 24, 16:00
48.85
0.00 (0.00%)
After-Hours: 20:00
Alkermes Market Cap : 8.184B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.097B |
| August 20, 2026 | 8.045B |
| August 19, 2026 | 8.407B |
| August 18, 2026 | 8.290B |
| August 17, 2026 | 8.352B |
| August 14, 2026 | 8.220B |
| August 13, 2026 | 8.285B |
| August 12, 2026 | 8.424B |
| August 11, 2026 | 8.245B |
| August 10, 2026 | 8.277B |
| August 07, 2026 | 8.238B |
| August 06, 2026 | 8.104B |
| August 05, 2026 | 8.312B |
| August 04, 2026 | 8.322B |
| August 03, 2026 | 8.298B |
| July 31, 2026 | 8.208B |
| July 30, 2026 | 8.382B |
| July 29, 2026 | 8.099B |
| July 28, 2026 | 8.461B |
| July 27, 2026 | 8.834B |
| July 24, 2026 | 8.861B |
| July 23, 2026 | 8.875B |
| July 22, 2026 | 8.753B |
| July 21, 2026 | 8.798B |
| July 20, 2026 | 8.609B |
| Date | Value |
|---|---|
| July 17, 2026 | 8.776B |
| July 16, 2026 | 8.646B |
| July 15, 2026 | 8.653B |
| July 14, 2026 | 8.589B |
| July 13, 2026 | 8.634B |
| July 10, 2026 | 8.646B |
| July 09, 2026 | 8.952B |
| July 08, 2026 | 9.037B |
| July 07, 2026 | 9.192B |
| July 06, 2026 | 9.179B |
| July 02, 2026 | 9.086B |
| July 01, 2026 | 8.609B |
| June 30, 2026 | 8.722B |
| June 29, 2026 | 8.744B |
| June 26, 2026 | 9.169B |
| June 25, 2026 | 8.794B |
| June 24, 2026 | 8.398B |
| June 23, 2026 | 8.002B |
| June 22, 2026 | 7.661B |
| June 18, 2026 | 7.489B |
| June 17, 2026 | 7.409B |
| June 16, 2026 | 7.339B |
| June 15, 2026 | 7.384B |
| June 12, 2026 | 7.371B |
| June 11, 2026 | 7.477B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 290.25M |
| Jazz Pharmaceuticals Plc | 16.48B |
| Prothena Corp. Plc | 485.36M |
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Biogen, Inc. | 32.21B |
Market Cap Related Metrics
| PE Ratio | 126.88 |
| PS Ratio | 4.963 |
| Price to Book Value | 4.525 |
| Price to Free Cash Flow | 37.34 |
| Price | 48.85 |
| Earnings Yield | 0.79% |
| Operating PE Ratio | 57.61 |
| Normalized PE Ratio | 99.37 |